RSI Chief Medical Officer, Dr. Donald R. Mattison, in collaboration with colleagues from the Institute for Safe Medication Practices and Wake Forest University, evaluated and compared the safety profiles of newer contraceptives using 43,324 adverse event case reports submitted to the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS), for the two years ending July 2017. The presentation on Saturday, March 10, 2018 in San Diego described the strong safety profiles of the newer contraceptives, as well as issues of concern.
For more details see the presentation poster here.
More RSI News
RSI contributes to newly published book on Blood Safety.
Written by experts in the field, Blood Safety: A Guide to Monitoring and Responding to Potential New Threats offers a concise yet comprehensive overview on critical issues in monitoring…
RSI Provides Technical Advice and Review to Vietnam Partners and on-site Climate Support for Workshop
Engineers Canada is a partner with the German development agency Deutsche Gesellschaft für Internationale Zusammenarbeit GmbH (GIZ) in the execution of their Enhanced Climate Services…
Neil Comer to present at OPTrust Climate Change Symposium
The OPTrust Climate Change Symposium being held NOVEMBER 19-20, 2018 in TORONTO offers an opportunity to provide new insights into how to face climate change…
Emma Hartnett 2018 recipient of Center for Produce Safety (CPS) Research Award
CPS has recently announced 13 new research awards totaling a little over $2.6 million. The awards are for research projects directed at answering critical questions…